Merith Basey News Today

What the Inflation Reduction Act means for the cost of health care | United States

Manufacturers of 10 drugs have 30 days to accept or make a counter-offer

The fight over Medicare drug price negotiation picked back up this week with oral arguments in AstraZeneca’s lawsuit and the federal government sending out its first offers for a maximum fair price to manufacturers. AstraZeneca on Wednesday gave its first oral arguments in the District Court of Delaware. Like other companies and pharmaceutical entities, the…

The Lower Costs, More Transparency Act has passed in the House with bipartisan support. The action is being applauded from several advocacy organizations.

In a letter to Senate leadership, several organizations asked for the passing of legislation that would reform the patent system and improve competition in the prescription drug space.

Merith Basey, executive director of Patients For Affordable Drugs, believes the Medicare price negotiation program is here to stay, no matter who is president and no matter how many Big Pharma players file lawsuits. Her reasoning? Every other high income nation has been negotiating prices with drugmakers for years, and the program is widely popular in the U.S. among pretty much everyone who isn’t a pharma company, she said during a session at Engage at HLTH.

The opening day of the HLTH 2023 event offered a surprising announcement from venture capital firm General Catalyst. Weight Watchers CEO called for a change in how we talk about obesity. ENGAGE at HLTH offered compelling discussions around retail health, prescription drug prices and investment trends.

A high-profile case in in Amarillo, Texas could wipe out access to the abortion pill mifepristone nationwide, Alice reports.

Novo Nordisk, Sanofi face pressure to cut insulin prices following Eli Lilly’s move. From PR Week

After several rounds of treatment for a rare eye cancer—weekly drug infusions that could cost nearly $50,000 each—Paul ...